World's top Biotechnology & Medical Research stocks
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
RXDXPrometheus Biosciences | $9.56bn | n/a | n/a |
QGENQiagen NV | $8.85bn | 24.01 | n/a |
IMGNImmunoGen | $8.72bn | n/a | n/a |
LEGNLegend Biotech | $8.40bn | n/a | n/a |
ASNDAscendis Pharma A/S | $8.09bn | n/a | n/a |
CERECerevel Therapeutics Holdings | $7.66bn | n/a | n/a |
CYTKCytokinetics | $7.06bn | n/a | n/a |
VKTXViking Therapeutics | $6.99bn | n/a | n/a |
2269WuXi Biologics (Cayman) | HK$53.75bn | 14.88 | n/a |
EXELExelixis | $6.64bn | 34.84 | n/a |
PCVXVaxcyte | $6.62bn | n/a | n/a |
RETAReata Pharmaceuticals | $6.52bn | n/a | n/a |
BANBBACHEM HOLDING AG | CH₣5.90bn | 52.3 | 1.02% |
IONSIonis Pharmaceuticals | $5.93bn | n/a | n/a |
RVMDRevolution Medicines | $5.75bn | n/a | n/a |
ISEEIVERIC bio | $5.51bn | n/a | n/a |
IMCRImmunocore Holdings | $5.39bn | n/a | n/a |
BPMCBlueprint Medicines | $5.32bn | n/a | n/a |
ZEALZealand Pharma A/S | DKK36.34bn | n/a | n/a |
HALOHalozyme Therapeutics | $4.91bn | 18.28 | n/a |